Free Trial
NASDAQ:RPID

Rapid Micro Biosystems Q2 2025 Earnings Report

Rapid Micro Biosystems logo
$3.31 -0.02 (-0.60%)
Closing price 08/1/2025 04:00 PM Eastern
Extended Trading
$3.30 0.00 (-0.15%)
As of 08/1/2025 07:23 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Rapid Micro Biosystems EPS Results

Actual EPS
N/A
Consensus EPS
-$0.26
Beat/Miss
N/A
One Year Ago EPS
N/A

Rapid Micro Biosystems Revenue Results

Actual Revenue
N/A
Expected Revenue
$7.10 million
Beat/Miss
N/A
YoY Revenue Growth
N/A

Rapid Micro Biosystems Announcement Details

Quarter
Q2 2025
Time
Before Market Opens
Conference Call Date
Tuesday, August 12, 2025
Conference Call Time
8:30AM ET

Conference Call Resources

Rapid Micro Biosystems Earnings Headlines

Market Panic: Trump Just Dropped a Bomb on Your Stocks
tock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tariffs just lit the fuse. Millions of investors are blindsided as stocks plunge… but this is only Phase 1. If you're still holding the wrong assets, you could lose 30% or more in the coming weeks.
Rapid Micro Biosystems (RPID) Expected to Announce Earnings on Friday
See More Rapid Micro Biosystems Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Rapid Micro Biosystems? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Rapid Micro Biosystems and other key companies, straight to your email.

About Rapid Micro Biosystems

Rapid Micro Biosystems (NASDAQ:RPID), a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, medical devices, and personal care products in the United States, Germany, Switzerland, Japan, and internationally. The company offers Growth Direct platform, which includes Growth Direct system, proprietary consumables, lab information management system connection software, and customer support and validation services. Its platform automates and modernizes the manual microbial quality control (MQC) testing workflows for therapeutic modalities, such as biologics, vaccines, cell and gene therapies, and sterile injectables. The company also provides onsite technical training services. Its solutions are used in environmental monitoring, water, bioburden, and sterility release testing applications. In addition, the company offers RMBNucleus software for the Growth Direct system; RMBNucleus Mold Alarm signals at the first sign of mold detection; RMBNucleus Central Manager portal streamlines coordination of multiple instruments; and Growth Direct LIMS connection software. Rapid Micro Biosystems, Inc. was formerly known as Genomic Profiling Systems, Inc. and changed its name to Rapid Micro Biosystems, Inc. in January 2007. The company was incorporated in 2006 and is headquartered in Lowell, Massachusetts.

View Rapid Micro Biosystems Profile

More Earnings Resources from MarketBeat